Last reviewed · How we verify
NCT05037539
Efficacy of Injectable Fentanyl in Sublingual Route Versus Oral Morphine Syrup for Breakthrough Pain
Phase 1, PHASE2 trial testing Fentanyl Citrate 50Mcg/Ml Inj_#1 in Pain, Breakthrough in 20 participants. Completed in 30 June 2022.
30 December 2021
Quick facts
| Lead sponsor | Department of Medical Services Ministry of Public Health of Thailand |
|---|---|
| Phase | Phase 1, PHASE2 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | single group |
| Masking | triple |
| Primary purpose | supportive care |
| Enrollment | 20 |
| Start date | 15 June 2021 |
| Primary completion | 30 December 2021 |
| Estimated completion | 30 June 2022 |
| Sites | 1 location across Thailand |
Drugs / interventions tested
- Fentanyl Citrate 50Mcg/Ml Inj_#1 — full drug profile →
- Morphine
Conditions studied
- Pain, Breakthrough — all drugs for Pain, Breakthrough →
Sponsor
Department of Medical Services Ministry of Public Health of Thailand
Who can join
Eligibility, female only, with Pain, Breakthrough. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Randomized control trial that to comparison the efficacy of injectable fentanyl in sublingual route versus oral morphine syrup for breakthrough pain in gynecologic cancer patients with chronic cancer pain Primary outcome : to measure pain score after drug is given
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Efficacy of reconstituted intravenous fentanyl to sublingual solution versus oral morphine syrup for breakthrough pain among patients with chronic gynecologic cancer pain: A randomized, double-blind, placebo-controlled trial.
Thantiprechapong T, Tilagul T, Vasikasin V. · · 2023 · cited 1× · PMID 37170709 · DOI 10.1111/jog.15674
Verify or expand the search:
- PubMed search for NCT05037539
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Department of Medical Services Ministry of Public Health of Thailand trials
Trials by the same sponsor.
- NCT06665737 — Outcomes of Early and Late Administration G-CSF for Primary Prophylaxis in Non-Hodgkin's Lymphoma Patients · Phase 4 · not yet recruiting
- NCT06763575 — Efficacy of Surgical Glove-Compression Therapy As a Prevention of Paclitaxel-Induced Peripheral Neuropathy · NA · recruiting
- NCT06860659 — Efficacy of 0.28% Sodium Hyaluronate Eye Drops in Patient With Moderate to Severe Dry Eye · Phase 4 · enrolling by invitation
- NCT06525870 — Efficacy of Topical 85% TCA in the Treatment of LSIL After Low-grade Abnormality of Screening Test: a Randomized Control · Phase 2 · enrolling by invitation
- NCT06436833 — Comparison of Bowel Preparation Using 2 Liter Polyethylene Glycol Regimen Plus Elobixibat Versus 4-Liter Polyethylene Gl · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05037539 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Department of Medical Services Ministry of Public Health of Thailand
- Last refreshed: 31 August 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05037539.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing